Bill Search

  • Introduced
    Mar 16, 2020
  • Passed Senate
  • Passed Assembly
  • Signed into Law
S 2035
New Jersey Senate Bill
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Last Action
Senate • Feb 09, 2021: Reported from Senate Committee with Amendments, 2nd Reading
Latest bill text

Official Summary/Bill Text

Comments on Bill

Tweets

Do you support this bill?
Yay Nay
Sponsors:
Actions
  • Feb 09, 2021 | Senate
    • Reported from Senate Committee with Amendments, 2nd Reading
  • Mar 16, 2020 | Senate
    • Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Documents